07.16.15
San Diego, Calif.-based spine company NuVasive Inc. has appointed Jason M. Hannon has been appointed executive vice president, international, where he will be responsible for the company's business and commercial operations outside of the United States, including leading the company's international expansion opportunities.
The appointment of Hannon marks an important strategic step in support of NuVasive's commitment to accelerate its global expansion and market share-taking efforts in key international growth markets. Hannon will relocate to NuVasive's international headquarters in Amsterdam, the Netherlands. The company sells in more than 30 countries, including Japan, Australia, the United Kingdom, Italy, Germany, Spain, Argentina, Brazil and throughout Southeast Asia.
"We are pleased to have Jason leading our highly capable international team as we look to capitalize on the strong foundation we have built across our Latin America, European and Asia-Pacific markets," said Gregory T. Lucier, NuVasive's chairman and CEO. "As a ten-year veteran of NuVasive, Jason is uniquely positioned to lead our international expansion efforts. He brings vast knowledge of not only our company, but of the global markets and competitive landscape to his new role, as well as business acumen and extensive corporate development experience. With Jason now leading our efforts internationally, we are well positioned to deliver on NuVasive's next phase of growth and success as the innovation pioneer in spine on a truly global basis."
Hannon said: "My immediate focus will be centered on globalizing our business growth, including accelerating investments for rapid growth in specific and targeted ways, as well as aggressively pursuing inorganic growth options to supplement NuVasive's already strong organic expansion. Equally as important will be to ensure NuVasive shareowners around the world have a truly global mindset with a talent base that is strategically aligned. I look forward to spending time in each of our markets, helping to understand the barriers to our growth and prioritizing our most important investments."
Hannon brings to his new role extensive experience in key areas of NuVasive's business, including corporate development, mergers and acquisitions, regulatory and legal expertise. Throughout his tenure at NuVasive, he has been involved in developing and driving the company's strategic direction and has played a key leadership role in support of NuVasive's business growth. Hannon will continue to serve as NuVasive's general counsel until a successor is identified, for which an active search is underway.
The appointment of Hannon marks an important strategic step in support of NuVasive's commitment to accelerate its global expansion and market share-taking efforts in key international growth markets. Hannon will relocate to NuVasive's international headquarters in Amsterdam, the Netherlands. The company sells in more than 30 countries, including Japan, Australia, the United Kingdom, Italy, Germany, Spain, Argentina, Brazil and throughout Southeast Asia.
"We are pleased to have Jason leading our highly capable international team as we look to capitalize on the strong foundation we have built across our Latin America, European and Asia-Pacific markets," said Gregory T. Lucier, NuVasive's chairman and CEO. "As a ten-year veteran of NuVasive, Jason is uniquely positioned to lead our international expansion efforts. He brings vast knowledge of not only our company, but of the global markets and competitive landscape to his new role, as well as business acumen and extensive corporate development experience. With Jason now leading our efforts internationally, we are well positioned to deliver on NuVasive's next phase of growth and success as the innovation pioneer in spine on a truly global basis."
Hannon said: "My immediate focus will be centered on globalizing our business growth, including accelerating investments for rapid growth in specific and targeted ways, as well as aggressively pursuing inorganic growth options to supplement NuVasive's already strong organic expansion. Equally as important will be to ensure NuVasive shareowners around the world have a truly global mindset with a talent base that is strategically aligned. I look forward to spending time in each of our markets, helping to understand the barriers to our growth and prioritizing our most important investments."
Hannon brings to his new role extensive experience in key areas of NuVasive's business, including corporate development, mergers and acquisitions, regulatory and legal expertise. Throughout his tenure at NuVasive, he has been involved in developing and driving the company's strategic direction and has played a key leadership role in support of NuVasive's business growth. Hannon will continue to serve as NuVasive's general counsel until a successor is identified, for which an active search is underway.